ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $172,000 | -45.2% | 131,638 | -26.3% | 0.00% | – |
| Q4 2021 | $314,000 | +44.7% | 178,586 | +78.2% | 0.00% | – |
| Q3 2021 | $217,000 | -56.7% | 100,200 | -30.0% | 0.00% | – |
| Q2 2021 | $501,000 | +18.4% | 143,051 | +233.6% | 0.00% | – |
| Q1 2021 | $423,000 | +48.4% | 42,878 | +62.8% | 0.00% | – |
| Q4 2020 | $285,000 | +31.9% | 26,333 | +25.7% | 0.00% | – |
| Q3 2020 | $216,000 | -82.4% | 20,955 | -64.4% | 0.00% | -100.0% |
| Q2 2020 | $1,229,000 | +395.6% | 58,841 | +132.2% | 0.00% | – |
| Q1 2020 | $248,000 | +6.4% | 25,342 | +25.1% | 0.00% | – |
| Q4 2019 | $233,000 | +187.7% | 20,264 | +35.6% | 0.00% | – |
| Q3 2019 | $81,000 | -93.7% | 14,939 | -86.3% | 0.00% | -100.0% |
| Q2 2019 | $1,295,000 | +2171.9% | 108,953 | +901.2% | 0.00% | – |
| Q1 2019 | $57,000 | +46.2% | 10,882 | -30.7% | 0.00% | – |
| Q2 2017 | $39,000 | -72.9% | 15,710 | -70.5% | 0.00% | – |
| Q1 2017 | $144,000 | +69.4% | 53,218 | +81.5% | 0.00% | – |
| Q4 2016 | $85,000 | -40.1% | 29,320 | -15.0% | 0.00% | – |
| Q3 2016 | $142,000 | +56.0% | 34,479 | +19.1% | 0.00% | – |
| Q2 2016 | $91,000 | – | 28,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |